<DOC>
	<DOC>NCT01872715</DOC>
	<brief_summary>The purpose of this study is to characterize rosacea patients', being treated with Oracea, perception through visual analog scale reporting.</brief_summary>
	<brief_title>Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Men and women 2570 years Diagnosis of papulopustular rosacea Eligible for Oracea treatment Allergies to components of investigational product and/or hypersensitivity to tetracyclines Taken systemic therapy directed at improving rosacea, including antibiotics, within 30 days prior to baseline visit Used topical rosacea treatment within 30 days prior to baseline visit Have active ocular rosacea and/or blepharitis/meibomianitis requiring systemic treatment by an opthalmologist Previously failed to have improvement of rosacea with appropriate use of systemic tetracycline family of antibiotics Exposed to intense/excessive ultraviolet (UV) radiation within one week prior to baseline and/or who forsee unprotected and intense/excessive UV exposure during the course of the study Have planned surgical procedures during the course of the study Have used tetracycline antibiotics within 30 days prior to baseline visit or during study At risk in terms of precautions, warnings, and contraindications</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Papulopustular Rosacea</keyword>
	<keyword>Oracea</keyword>
	<keyword>anti inflammatory doxycycline</keyword>
</DOC>